Centralised ECGs Help Ensure Cardiac Safety of Obesity Drugs

Sep 28, 2012

Robert Kleiman at ERT discusses how centralised ECG trials have emerged as a viable method for helping drug companies provide reliable cardiovascular data in their attempts to achieve regulatory compliance, while also benefiting from significantly improved data accuracy and reliability, time and cost savings, and access to breakthrough technologies. ...

Read More